customerservice@curanthealth.com
866-460-8040

Curant Newsroom

Curant Rare Selected to Provide Patient Support Services for HEMA Biologics Cares™ and SEVENFACT®

Curant Rare will provide access and patient support services for eligible patients prescribed SEVENFACT®   ATLANTA, GA November 4, 2026 — Curant Health is proud to announce that Curant Rare, a rare disease pharmacy specializing in personalized support for patients with rare and complex conditions, has been selected to administer and support the HEMA Biologics […]

Read More
Curant Rare and IntraBio Expand Collaboration Following FDA Approval of AQNEURSA® for the treatment of Ataxia in patients with Ataxia-Telangiectasia

ATLANTA, GA – October 5, 2026 – Curant Rare has announced the expansion of its collaboration with IntraBio following U.S. Food and Drug Administration approval of AQNEURSA® (levacetylleucine) for the treatment ataxia in adults and pediatric patients with ataxia-telangiectasia (A-T) weighing ≥ 15 kg. As the exclusive rare disease pharmacy for AQNEURSA, Curant Rare will […]

Read More
The Growing Importance of Evidence in Rare Disease

The Future of Rare Disease Commercialization Won’t Be Defined by Access Alone   Biopharmaceutical companies invest years of development, millions of dollars, and extraordinary scientific expertise to bring rare disease therapies to market. Yet many continue to evaluate pharmacy partners using criteria built for a different era. Distribution.  Dispensing.  Fulfillment.  While those capabilities remain essential, they are no longer enough.  Which […]

Read More
Diabetes Care is Evolving, Health Plans Need More Than Medication to Improve Outcomes

Diabetes has become one of the most significant healthcare challenges facing health plans today. What was once viewed primarily as a chronic medical condition is now a complex population health issue that impacts quality performance, healthcare costs, member satisfaction, and long-term outcomes. [cdc.gov] More than 40 million Americans are currently living with diabetes, representing approximately […]

Read More
Curant Health Named a Winner of Multiple 2026 Top Workplace Honors

SMYRNA, GEORGIA, Aug. 18, 2026 - Curant Health has been named a 2026 Atlanta Top Workplace and Healthcare Top Workplace by Axios, earning additional Cultural Excellence honors for Work-Life Flexibility, Purpose & Values, Professional Development, Leadership, Innovation, and Appreciation. The recognition reflects Curant Health’s commitment to building an employee-centered culture where people are empowered to grow, innovate, and make […]

Read More
Curant Rare and IntraBio Bring Real-World Evidence to Niemann-Pick Disease Type C Care

Real-world data is essential to understanding how therapies perform beyond clinical trials, particularly in rare diseases like Niemann-Pick disease type C (NPC). As healthcare increasingly prioritizes evidence that reflects everyday patient experience, the need for meaningful patient-reported outcomes continues to grow. In collaboration with IntraBio, Curant Rare developed a first-of-its-kind real-world evidence (RWE) system that […]

Read More
Case Study: How Medication Care Management Transforms Heart Failure Care and Cuts Costs in Rural Wisconsin Community

PlanPlus by Curant Health Serves Security Health Plan Heart Failure Members and Significantly Reduces Total Cost of Care in One Year.   Authors: Jeremy Combs, MBA1 (Corresponding author: jcombs@curanthealth.com)   John Cox, MD2   Paula Jacobson3     Executive Summary In 2023, Security Health Plan (SHP) partnered with PlanPlus by Curant Health to address rising Total Cost of Care (TCOC) among members diagnosed with Congestive Heart Failure (CHF). Heart failure is one of […]

Read More
PlanPlus: The Intersection of Confidence and Competence in Understanding Medicare Stars Rating Cut Points

Each year, Medicare Stars cut points continue to rise, and 2026 is no exception. Nearly 60% of all cut points increased year over year, including approximately 60% of 4-Star thresholds, further reinforcing how challenging it has become to achieve and sustain high performance. As expectations continue to climb, plans must shift from reactive adjustments to […]

Read More
Curant Rare Announces Collaboration with Cencora to Support Commercialization of Rare and Orphan Drug Products

Atlanta, GA – Curant Rare today announced a strategic collaboration with Cencora, a global pharmaceutical solutions organization, that aims to provide pharmaceutical companies developing rare disease therapies with an integrated solution to support the commercialization of their products.   Rare disease therapies face unique challenges, including complex regulatory pathways and access barriers. This collaboration will leverage Cencora’s pharmaceutical logistics services and commercialization solutions, such as pharmacovigilance and market access support, and Curant Rare’s specialty pharmacy services and omnichannel patient engagement solutions.   The integrated solution aims to streamline […]

Read More
Curant Rare Announces Pharmacy Partnership with Corcept Therapeutics

ATLANTA--(BUSINESS WIRE)--Curant Health is proud to announce that Curant Rare has been selected by Corcept Therapeutics as a specialty pharmacy to provide personalized care, coordinated access to therapy, and comprehensive support to help patients and caregivers navigate the complexities of treatment. Patients will now benefit from Curant Rare’s proven high-touch care model, designed to ensure […]

Read More
1 2 3 … 26

phone

866-460-8040

Headquarters

200 Technology Ct., Suite B
Smyrna, GA 30082

E-mail

customerservice

@curanthealth.com
homeenvelopephonemenu-circlecross-circle linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram Skip to content